KFF Health News Colorado correspondent Rae Ellen Bichell discussed farmworkers and their risk of contracting bird flu on KGNU on Sept. 5. Click here to hear Bichell on KGNU Read Bichell’s “With Only Gloves To Protect Them, Farmworkers Say They Tend Sick Cows Amid Bird Flu” KFF Health News Northern California correspondent Vanessa G. Sánchez…
By actively and consistently collecting feedback, hospitals can gain rapid insights into critical areas, allowing them to track and measure patient satisfaction levels, and crucially to react to any dips in standards of care. The post How Data Feedback Can Aid Patient Experience in Healthcare appeared first on MedCity News.
Check out news from Oral Genome, Carrot Fertility, Thatch, and The Perryman Group. The post StartUPDATES: New Developments for Healthcare Startups appeared first on MedCity News.
Local health department staffing grew by about 19% from 2019 to 2022, according to a report from the National Association of County and City Health Officials that studied 2,512 of the nation’s roughly 3,300 local departments. But those jobs, and the safety net they provide for the people in the communities served, are vulnerable as…
The FDA decision for Travere Therapeutics’ Filspari also expands its addressable patient population. The full approval comes nearly a year after the Travere drug narrowly missed the main goal of its confirmatory study. The post Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas appeared first on MedCity News.
Mayo Clinic recently launched a collaboration with Exer AI, a Denver-based startup. The AI company seeks to improve diagnosis and treatment for musculoskeletal and motion disorders wherever the patient is — whether that be in their provider’s office, their home or via telehealth appointment. The post Mayo Clinic Taps AI Startup to Improve MSK Care…
Aon Plc estimates U.S. employer healthcare costs to rise 9 percent in the coming year
More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues, according to a new KFF analysis. Though only about 3% of adults with employer coverage…More
